Entry
Name
Human papillomavirus infection - Macaca mulatta (rhesus monkey)
Description
Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus. HPV infect mucoal and cutaneous epithelium resulting in several types of pathologies, most notably, cervical cancer. All types of HPV share a common genomic structure and encode eight proteins: E1, E2, E4, E5, E6, and E7 (early) and L1 and L2 (late). It has been demonstrated that E1 and E2 are involved in viral transcription and replication. The functions of the E4 protein is not yet fully understood. E5, E6, and E7 act as oncoproteins. E5 inhibits the V-ATPase, prolonging EGFR signaling and thereby promoting cell proliferation. The expression of E6 and E7 not only inhibits the tumor suppressors p53 and Rb, but also alters additional signalling pathways. Among these pathways, PI3K/Akt signalling cascade plays a very important role in HPV-induced carcinogenesis. The L1 and L2 proteins form icosahedral capsids for progeny virion generation.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Organism
Macaca mulatta (rhesus monkey) [GN:
mcc ]
Gene
100187576 MAMU-AG; major histocompatibility complex, class I, AG precursor [KO:K06751 ]
100423838 DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353 ]
100425716 ATP6V0C; V-type proton ATPase 16 kDa proteolipid subunit [KO:K02155 ]
100427351 HES3; LOW QUALITY PROTEIN: transcription factor HES-3 [KO:K09088 ]
114669841 PPP2R3B; LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta [KO:K11583 ]
574159 FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389 ]
574201 COL1A1; collagen alpha-1(I) chain isoform X1 [KO:K06236 ]
574209 VEGFA; vascular endothelial growth factor A isoform 1 precursor [KO:K05448 ]
574294 TICAM1; TIR domain-containing adapter molecule 1 [KO:K05842 ]
574332 FAS; tumor necrosis factor receptor superfamily member 6 precursor [KO:K04390 ]
677865 ATP6V0A1; V-type proton ATPase 116 kDa subunit a isoform X4 [KO:K02154 ]
693323 ATP6V1H; V-type proton ATPase subunit H isoform X1 [KO:K02144 ]
693443 APC; adenomatous polyposis coli protein isoform X1 [KO:K02085 ]
693650 STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220 ]
693838 ATP6V0D2; V-type proton ATPase subunit d 2 [KO:K02146 ]
693840 ATP6V1C1; V-type proton ATPase subunit C 1 [KO:K02148 ]
693961 TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174 ]
694248 COL9A2; collagen alpha-2(IX) chain isoform X2 [KO:K08131 ]
694560 TCF7L1; transcription factor 7-like 1 isoform X2 [KO:K04490 ]
694601 RBPJ; recombining binding protein suppressor of hairless [KO:K06053 ]
694616 PPP2R3C; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma isoform X1 [KO:K11583 ]
694701 COL6A3; collagen alpha-3(VI) chain isoform X4 [KO:K06238 ]
694929 HES5; transcription factor HES-5 isoform X1 [KO:K06055 ]
695118 PPP2CB; serine/threonine-protein phosphatase 2A catalytic subunit beta isoform [KO:K04382 ] [EC:3.1.3.16 ]
695220 PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261 ]
696350 CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048 ]
696663 BCAP31; B-cell receptor-associated protein 31 isoform X1 [KO:K14009 ]
696685 LAMA4; laminin subunit alpha-4 isoform X1 [KO:K06241 ]
696992 RBL2; retinoblastoma-like protein 2 isoform X1 [KO:K16332 ]
697188 CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624 ]
697371 TBPL2; TATA box-binding protein-like protein 2 [KO:K03120 ]
697718 CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047 ]
697799 PSMC1; proteasome (prosome, macropain) 26S subunit, ATPase, 1 [KO:K03062 ]
698092 MAGI1; membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X13 [KO:K05631 ]
698160 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X1 [KO:K03171 ]
698345 ATP6V0D1; V-type proton ATPase subunit d 1 isoform X1 [KO:K02146 ]
698619 EGF; pro-epidermal growth factor isoform X2 [KO:K04357 ]
698943 OASL; 2'-5'-oligoadenylate synthase-like protein [KO:K14608 ]
698996 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha [KO:K02649 ]
699163 PPP2R5D; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform X1 [KO:K11584 ]
699243 MAMU-A3; major histocompatibility complex, class I, A isoform X1 [KO:K06751 ]
699351 PARD6A; partitioning defective 6 homolog alpha [KO:K06093 ]
699385 HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091 ]
699479 PARD6G; partitioning defective 6 homolog gamma [KO:K06093 ]
699520 PPP2R2D; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform isoform X1 [KO:K04354 ]
699604 IFNAR1; interferon alpha/beta receptor 1 precursor [KO:K05130 ]
699726 IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131 ]
700074 MAML2; mastermind-like protein 2 isoform X1 [KO:K06061 ]
700359 COL1A2; collagen alpha-2(I) chain precursor [KO:K06236 ]
700382 CCNE2; G1/S-specific cyclin-E2 isoform X2 [KO:K06626 ]
700589 CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626 ]
701237 IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210 ]
701313 LAMA3; laminin subunit alpha-3 isoform X1 [KO:K06240 ]
701650 RBL1; LOW QUALITY PROTEIN: retinoblastoma-like protein 1 [KO:K04681 ]
701759 TCF7L2; transcription factor 7-like 2 isoform X9 [KO:K04491 ]
702041 GRB2; growth factor receptor-bound protein 2 [KO:K04364 ]
702243 ATP6V0B; V-type proton ATPase 21 kDa proteolipid subunit [KO:K03661 ]
702945 NFX1; transcriptional repressor NF-X1 isoform X1 [KO:K12236 ]
703342 ATP6V0E1; V-type proton ATPase subunit e 1 [KO:K02153 ]
703628 EIF4EBP1; eukaryotic translation initiation factor 4E-binding protein 1 [KO:K07205 ]
703646 ATP6V1B1; V-type proton ATPase subunit B, kidney isoform isoform X1 [KO:K02147 ]
703655 ATP6V1G1; V-type proton ATPase subunit G 1 [KO:K02152 ]
703707 COL4A6; collagen alpha-6(IV) chain isoform X1 [KO:K06237 ]
703814 COL4A5; collagen alpha-5(IV) chain isoform X1 [KO:K06237 ]
703933 SLC9A3R1; Na(+)/H(+) exchange regulatory cofactor NHE-RF1 [KO:K13365 ]
704851 COL2A1; collagen alpha-1(II) chain isoform X2 [KO:K19719 ]
705605 ATP6V1B2; LOW QUALITY PROTEIN: V-type proton ATPase subunit B, brain isoform [KO:K02147 ]
705864 DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353 ]
706472 PARD3; partitioning defective 3 homolog isoform X1 [KO:K04237 ]
706672 HES6; transcription cofactor HES-6 isoform X1 [KO:K09087 ]
706673 ATP6V1C2; V-type proton ATPase subunit C 2 isoform X3 [KO:K02148 ]
706973 LLGL2; lethal(2) giant larvae protein homolog 2 isoform X1 [KO:K06094 ]
706988 PPP2R2B; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1 [KO:K04354 ]
707310 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649 ]
707345 APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085 ]
707405 LLGL1; lethal(2) giant larvae protein homolog 1 isoform X1 [KO:K06094 ]
707637 CDC42; cell division control protein 42 homolog [KO:K04393 ]
708287 COL4A4; collagen alpha-4(IV) chain isoform X1 [KO:K06237 ]
708583 PPP2R5E; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform [KO:K11584 ]
708606 FADD; FAS-associated death domain protein [KO:K02373 ]
708717 CREB1; cyclic AMP-responsive element-binding protein 1 [KO:K05870 ]
708912 EIF2AK2; interferon-induced, double-stranded RNA-activated protein kinase [KO:K16195 ] [EC:2.7.11.1 ]
709076 MAMU-F; mamu class I histocompatibility antigen, alpha chain F precursor [KO:K06751 ]
709493 COL6A2; collagen alpha-2(VI) chain isoform X2 [KO:K06238 ]
709511 CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X3 [KO:K04467 ] [EC:2.7.11.10 ]
709739 ATP6V1E1; V-type proton ATPase subunit E 1 isoform X1 [KO:K02150 ]
709947 NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599 ]
709959 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
710049 MPP5; MAGUK p55 subfamily member 5 isoform X1 [KO:K06091 ]
710162 ATP6V0A2; V-type proton ATPase 116 kDa subunit a [KO:K02154 ]
710324 NFKB1; nuclear factor NF-kappa-B p105 subunit [KO:K02580 ]
710326 PPP2CA; serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform isoform X1 [KO:K04382 ] [EC:3.1.3.16 ]
710372 ATP6V1G3; V-type proton ATPase subunit G 3 [KO:K02152 ]
710387 PPP2R1B; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X1 [KO:K03456 ]
710552 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
710650 TCIRG1; V-type proton ATPase 116 kDa subunit a isoform X1 [KO:K02154 ]
711023 PPP2R2C; protein phosphatase 2, regulatory subunit B, gamma [KO:K04354 ]
711532 MAMU-E; major histocompatibility complex, class I, E precursor [KO:K06751 ]
711832 MAMU-A; major histocompatibility complex, class I, A isoform X1 [KO:K06751 ]
711920 PPP2R2A; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform X1 [KO:K04354 ]
712004 PARD6B; partitioning defective 6 homolog beta [KO:K06093 ]
712444 COL4A3; collagen alpha-3(IV) chain isoform X1 [KO:K06237 ]
712694 STAT2; signal transducer and activator of transcription 2 [KO:K11221 ]
712988 HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091 ]
713162 CHD4; chromodomain-helicase-DNA-binding protein 4 isoform X12 [KO:K11643 ] [EC:5.6.2.-]
713262 TBPL1; TATA box-binding protein-like protein 1 [KO:K03120 ]
713391 CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 isoform X1 [KO:K09048 ]
713777 SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099 ]
713798 NOTCH2; neurogenic locus notch homolog protein 2 precursor [KO:K20994 ]
714381 DVL2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353 ]
714746 ATP6V1E2; V-type proton ATPase subunit E 2 [KO:K02150 ]
714809 COL9A1; collagen alpha-1(IX) chain isoform X4 [KO:K08131 ]
714981 CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048 ]
715186 MX1; interferon-induced GTP-binding protein Mx1 [KO:K14754 ]
715331 ATP6V1G2; V-type proton ATPase subunit G 2 [KO:K02152 ]
715394 LAMA2; laminin subunit alpha-2 isoform X1 [KO:K05637 ]
715492 ATP6V0A4; V-type proton ATPase 116 kDa subunit a [KO:K02154 ]
715919 RELA; transcription factor p65 isoform X1 [KO:K04735 ]
715951 CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 [KO:K09048 ]
716098 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
716117 HEYL; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091 ]
716313 PPP2R5A; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform [KO:K11584 ]
717078 PPP2R3A; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha [KO:K11583 ]
717323 NOTCH4; neurogenic locus notch homolog protein 4 isoform X1 [KO:K20996 ]
717625 RBPJL; recombining binding protein suppressor of hairless-like protein [KO:K06053 ]
717740 BAD; bcl2-associated agonist of cell death [KO:K02158 ]
718632 PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345 ] [EC:2.7.11.11 ]
718894 PPP2R5C; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X9 [KO:K11584 ]
719119 NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995 ]
719199 CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625 ]
719319 COL6A6; collagen alpha-6(VI) chain isoform X1 [KO:K06238 ]
719367 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649 ]
719929 PPP2R1A; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform [KO:K03456 ]
719943 COL9A3; collagen alpha-3(IX) chain isoform X2 [KO:K08131 ]
720286 COMP; cartilage oligomeric matrix protein [KO:K04659 ]
721821 MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369 ] [EC:2.7.12.2 ]
721825 CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048 ]
722026 PPP2R5B; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform [KO:K11584 ]
722033 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158 ]
722472 LAMA1; LOW QUALITY PROTEIN: laminin subunit alpha-1 [KO:K05637 ]
780935 MX2; interferon-induced GTP-binding protein Mx2 [KO:K14754 ]
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Moody CA, Laimins LA
Title
Human papillomavirus oncoproteins: pathways to transformation.
Journal
Reference
Authors
Chen J
Title
Signaling pathways in HPV-associated cancers and therapeutic implications.
Journal
Reference
Authors
Tummers B, Burg SH
Title
High-risk human papillomavirus targets crossroads in immune signaling.
Journal
Reference
Authors
Lehoux M, D'Abramo CM, Archambault J
Title
Molecular mechanisms of human papillomavirus-induced carcinogenesis.
Journal
Reference
Authors
Pang CL, Thierry F
Title
Human papillomavirus proteins as prospective therapeutic targets.
Journal
Reference
Authors
Yugawa T, Kiyono T
Title
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Journal
Reference
Authors
Narisawa-Saito M, Kiyono T
Title
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.
Journal
Reference
Authors
Wolf JK, Ramirez PT.
Title
The molecular biology of cervical cancer.
Journal
Reference
Authors
zur Hausen H
Title
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
Journal
Reference
Authors
Kim YT, Zhao M
Title
Aberrant cell cycle regulation in cervical carcinoma.
Journal
Reference
Authors
McCance DJ
Title
Human papillomaviruses and cell signaling.
Journal
Reference
Authors
Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T
Title
The role of human papilloma virus in the molecular biology of cervical carcinogenesis.
Journal
Kobe J Med Sci 50:9-19 (2004)
Reference
Authors
Tommasino M
Title
The human papillomavirus family and its role in carcinogenesis.
Journal
Reference
Authors
Bello JO, Nieva LO, Paredes AC, Gonzalez AM, Zavaleta LR, Lizano M
Title
Regulation of the Wnt/beta-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.
Journal
Reference
Authors
Shah M, Anwar MA, Park S, Jafri SS, Choi S
Title
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.
Journal
Reference
Authors
James CD, Roberts S
Title
Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?
Journal
Reference
Authors
Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaic V, Banks L
Title
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.
Journal
Reference
Authors
Subbaiah VK, Kranjec C, Thomas M, Banks L
Title
PDZ domains: the building blocks regulating tumorigenesis.
Journal
Reference
Authors
Banks L, Pim D, Thomas M
Title
Human tumour viruses and the deregulation of cell polarity in cancer.
Journal
Reference
Authors
Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L
Title
Human papillomaviruses, cervical cancer and cell polarity.
Journal
Reference
Authors
Jayshree RS, Sreenivas A, Tessy M, Krishna S
Title
Cell intrinsic & extrinsic factors in cervical carcinogenesis.
Journal
Indian J Med Res 130:286-95 (2009)
Reference
Authors
Garnett TO, Duerksen-Hughes PJ
Title
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.
Journal
Reference
Authors
Zhang L, Wu J, Ling MT, Zhao L, Zhao KN
Title
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.
Journal
Reference
Authors
Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G
Title
Papillomavirus E5: the smallest oncoprotein with many functions.
Journal
Reference
Authors
DiMaio D, Mattoon D
Title
Mechanisms of cell transformation by papillomavirus E5 proteins.
Journal
Reference
Authors
Ganguly N
Title
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.
Journal
Reference
Authors
DiMaio D, Petti LM
Title
The E5 proteins.
Journal
Reference
Authors
De Marco F
Title
Oxidative stress and HPV carcinogenesis.
Journal
Reference
Authors
Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA
Title
Breaking the DNA damage response to improve cervical cancer treatment.
Journal
Reference
Authors
Chung CH, Gillison ML
Title
Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Journal
Reference
Authors
Koromilas AE, Li S, Matlashewski G
Title
Control of interferon signaling in human papillomavirus infection.
Journal
Reference
Authors
Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ
Title
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.
Journal
Reference
Authors
Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J
Title
Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.
Journal
Reference
Authors
Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P
Title
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.
Journal
Reference
Authors
Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, Ning T, Basang Z, Zhang C, Ke Y
Title
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.
Journal
Reference
Authors
Xu M, Luo W, Elzi DJ, Grandori C, Galloway DA
Title
NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.
Journal
Reference
Authors
Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, Schelhaas M, Kast WM
Title
The evolving field of human papillomavirus receptor research: a review of binding and entry.
Journal
Related pathway
mcc04612 Antigen processing and presentation
mcc04620 Toll-like receptor signaling pathway
KO pathway